Startup profile · funding coverage
Counsel Health funding, valuation and investors
Physician-supervised async AI medical advice via messaging for employers and health plans.
Keep track of Counsel Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
$25M · 2025
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$36M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · New York, New York
Overview
Counsel Health combines AI-generated health guidance with licensed physician oversight — delivering async medical advice via secure messaging for employers and health plans. The hybrid model aims to scale primary-care access without replacing clinicians. Counsel raised an $11M seed in 2024 led by a16z Bio+Health with Asymmetric Capital, Floodgate, and Pear VC, then a $25M Series A in 2025 co-led by a16z and GV with Kleiner Perkins participating.
Why Counsel Health is interesting
Hybrid AI-clinician model for messaging-based care — Pear and Floodgate in seed; Kleiner joined a16z in the $25M Series A as employers seek scalable virtual primary care.
Product & use cases
Counsel delivers async medical messaging where AI drafts responses reviewed by licensed physicians — giving employees 24/7 access without synchronous telehealth waits.
- Employer-sponsored virtual primary care and triage
- Health-plan supplemental access for underserved members
- Chronic condition check-ins between in-person visits
Key facts
- Series A (2025): $25M co-led by a16z and GV; Kleiner Perkins participated (BusinessWire)
- Seed (2024): $11M led by a16z Bio+Health; Pear, Floodgate, Asymmetric (PR Newswire)
Funding history (newest first)
Series A
2025 $25MSource: https://www.businesswire.com/news/counsel-health-series-a
Investors in our directory
Funds linked from Counsel Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Physician-in-the-loop async model — AI handles volume while clinicians maintain medical liability and quality standards.
Virtual care platforms compete on employer contracts, clinical quality, and unit economics. Counsel's async AI+physician model targets lower cost per encounter than video visits. Regulatory scrutiny on AI medical advice makes physician oversight a differentiator.
-
98point6 direct
Text-based primary care; Counsel adds explicit AI+physician hybrid.
-
Teladoc incumbent
Broad telehealth incumbent; async messaging is one product line.
-
K Health direct
AI-first symptom checker with clinician chat; similar consumer/employer overlap.
-
Hims & Hers adjacent
DTC telehealth; narrower condition focus than primary care.
Notable stories
- Counsel's founders built the company on the thesis that most primary-care questions don't need a 15-minute video visit — async AI+physician messaging can scale access (a16z Bio+Health, 2024).
Industries
Related funding articles
Venture Capital Tracker pieces that cover Counsel Health's financing or category context.
FAQs about Counsel Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.